Finance

Lists
002020:SHE
Zhejiang Jingxin Pharmaceutical Co., Ltd
CN¥11,71
-1,35%
(-0,16) 1D
12 Okt., 14:59:06 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002020...
Open
CN¥11,91
High
CN¥12,02
Low
CN¥11,65
Mkt. cap
10,22 mjd
Avg. vol.
13,17 m
Volume
14,59 m
Dividend
2,99%
Quarterly dividend
CN¥0,09
Ex-dividend date
11 Jun. 2026
P/E ratio
13,11
52-wk high
CN¥21,65
52-wk low
CN¥11,11
EPS
CN¥0,89
Shares outstanding
861,03 m
No. of employees
4 k
Open
CN¥11,91
High
CN¥12,02
Low
CN¥11,65
Mkt. cap
10,22 mjd
Avg. vol.
13,17 m
Volume
14,59 m
Dividend
2,99%
Quarterly dividend
CN¥0,09
Ex-dividend date
11 Jun. 2026
P/E ratio
13,11
52-wk high
CN¥21,65
52-wk low
CN¥11,11
EPS
CN¥0,89
Shares outstanding
861,03 m
No. of employees
4 k
News stories
From web sources and news partners
About Zhejiang Jingxin Pharmaceutical Co., Ltd
CEO-
Employees3,73 k
Founded1990
Headquarters-
SectorPharmaceutical industry
Websitejingxinpharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,03 mjd
1,02 mjd
923,03 m
1,06 mjd
Cost of goods sold
506,52 m
540,75 m
451,52 m
554,56 m
Cost of revenue
506,52 m
540,75 m
451,52 m
554,56 m
Research and development expenses
89,68 m
93,56 m
83,03 m
81,74 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
220,72 m
200,08 m
186,30 m
185,69 m
Operating expense
333,83 m
292,95 m
280,97 m
282,38 m
Total operating expenses
840,35 m
833,70 m
732,49 m
836,94 m
Operating income
191,30 m
187,47 m
190,55 m
227,21 m
Other non operating income
-969,56 k
1,49 m
-14,07 m
13,33 m
EBT including unusual items
214,65 m
199,41 m
191,37 m
221,16 m
EBT excluding unusual items
206,53 m
197,34 m
189,61 m
241,52 m
Income tax expense
25,44 m
14,16 m
25,22 m
31,36 m
Effective tax rate
11,85%
7,10%
13,18%
14,18%
Other operating expenses
17,32 m
5,19 m
13,98 m
14,51 m
Net income
187,73 m
182,37 m
165,20 m
186,42 m
Net profit margin
18,20%
17,86%
17,90%
17,52%
Earnings per share
-
-
-
-
Interest and investment income
19,21 m
18,40 m
14,30 m
24,19 m
Interest expense
-1,63 m
-
-1,17 m
-390,99 k
Net interest expenses
17,58 m
18,40 m
13,14 m
23,80 m
Depreciation and amortization charges
-
-
-
-
EBITDA
260,03 m
254,25 m
257,33 m
293,99 m
Gain or loss from assets sale
-256,69 k
574,50 k
-
-6,12 m
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme